Recreational Nitrous Oxide Abuse : Prevalence, Neurotoxicity, and Treatment
Nitrous oxide (N2O), also known as "laughing gas," is a colorless, nonirritating gas. Clinically, it is widely used as an inhaled anesthetic, analgesic, and anxiolytic. In recent years, recreational abuse of N2O has become increasingly common, especially among young adults and adolescents, but many of them lack awareness of the possible side effects associated with this drug. N2O abuse can damage multiple systems, especially the nervous system, but the exact mechanism of N2O toxicity remains controversial. At present, an increasing number of cases of nervous system damage caused by N2O abuse have been reported both at home and abroad. Discontinuation of N2O use and timely supplementation with vitamin B12 are essential for a good prognosis. Long-term abuse without timely treatment will eventually lead to irreversible neurological damage. In this article, we discuss the epidemiology of N2O abuse, neurotoxicity mechanisms, clinical manifestations, relevant auxiliary examinations, treatments, and prognosis to improve social awareness of N2O exposure risk, especially among users and clinicians.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:39 |
---|---|
Enthalten in: |
Neurotoxicity research - 39(2021), 3 vom: 01. Juni, Seite 975-985 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Xiang, Yuanyuan [VerfasserIn] |
---|
Links: |
---|
Themen: |
Abuse |
---|
Anmerkungen: |
Date Completed 29.11.2021 Date Revised 29.11.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s12640-021-00352-y |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM323262821 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM323262821 | ||
003 | DE-627 | ||
005 | 20231225183816.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s12640-021-00352-y |2 doi | |
028 | 5 | 2 | |a pubmed24n1077.xml |
035 | |a (DE-627)NLM323262821 | ||
035 | |a (NLM)33770366 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Xiang, Yuanyuan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Recreational Nitrous Oxide Abuse |b Prevalence, Neurotoxicity, and Treatment |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 29.11.2021 | ||
500 | |a Date Revised 29.11.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Nitrous oxide (N2O), also known as "laughing gas," is a colorless, nonirritating gas. Clinically, it is widely used as an inhaled anesthetic, analgesic, and anxiolytic. In recent years, recreational abuse of N2O has become increasingly common, especially among young adults and adolescents, but many of them lack awareness of the possible side effects associated with this drug. N2O abuse can damage multiple systems, especially the nervous system, but the exact mechanism of N2O toxicity remains controversial. At present, an increasing number of cases of nervous system damage caused by N2O abuse have been reported both at home and abroad. Discontinuation of N2O use and timely supplementation with vitamin B12 are essential for a good prognosis. Long-term abuse without timely treatment will eventually lead to irreversible neurological damage. In this article, we discuss the epidemiology of N2O abuse, neurotoxicity mechanisms, clinical manifestations, relevant auxiliary examinations, treatments, and prognosis to improve social awareness of N2O exposure risk, especially among users and clinicians | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Abuse | |
650 | 4 | |a Neurotoxicity | |
650 | 4 | |a Nitrous oxide | |
650 | 4 | |a Prevalence | |
650 | 4 | |a Treatment | |
650 | 7 | |a Illicit Drugs |2 NLM | |
650 | 7 | |a Nitrous Oxide |2 NLM | |
650 | 7 | |a K50XQU1029 |2 NLM | |
650 | 7 | |a Vitamin B 12 |2 NLM | |
650 | 7 | |a P6YC3EG204 |2 NLM | |
700 | 1 | |a Li, Lei |e verfasserin |4 aut | |
700 | 1 | |a Ma, Xiaotong |e verfasserin |4 aut | |
700 | 1 | |a Li, Shan |e verfasserin |4 aut | |
700 | 1 | |a Xue, Yuan |e verfasserin |4 aut | |
700 | 1 | |a Yan, Peng |e verfasserin |4 aut | |
700 | 1 | |a Chen, Meijie |e verfasserin |4 aut | |
700 | 1 | |a Wu, Junwei |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Neurotoxicity research |d 1999 |g 39(2021), 3 vom: 01. Juni, Seite 975-985 |w (DE-627)NLM124802664 |x 1476-3524 |7 nnns |
773 | 1 | 8 | |g volume:39 |g year:2021 |g number:3 |g day:01 |g month:06 |g pages:975-985 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s12640-021-00352-y |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 39 |j 2021 |e 3 |b 01 |c 06 |h 975-985 |